Expanded Lung Cancer Claim For Lilly’s Cyramza Faces US FDA Scrutiny

 
• By Sue Sutter
  
Lung cancer ( film x-ray of chest PA upright : show pleural effusion at left lung due to lung cancer ) ( 2 type of lung cancer : Non-small cell lung cancer , Small cell carcinoma )
Lilly seeks to move Cyramza's metastatic non-small cell lung cancer indication into the first-line setting. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers